Porphyromonas Gingivalis and Alzheimer's Disease
NCT02109705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2023-05-31
Summary
With this study the investigators would like to analyze the the role of periodontal disease and especially the role of Porphyromonas gingivalis in initiation and progression of Alzheimer's Disease.
Conditions
- Alzheimer's Disease
- Dementia
- Periodontitis
Sponsors & Collaborators
-
University of Bern
collaborator OTHER -
University Hospital Muenster
lead OTHER
Principal Investigators
-
Oliver Laugisch, Dr med dent MAS · Department of Periodontology
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2021-01-31
- Completion
- 2021-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of a Low Protein Diet in Patients With Cognitive Impairment
NCT05480358 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy
NCT05905822 ·Status: COMPLETED
-
Effect of Insulin Sensitizer Metformin on AD Biomarkers
NCT01965756 ·Status: COMPLETED ·Phase: PHASE2
-
Gut Microbiota and Alzheimer's Diseases
NCT03827733 ·Status: UNKNOWN
-
Efficacy of HellenCare in Early-Stage Alzheimer's Disease
NCT06895525 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metformin in Alzheimer's Dementia Prevention
NCT04098666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
NCT04100889 ·Status: WITHDRAWN
-
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
NCT05267535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
NCT02615002 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
NCT04576793 ·Status: RECRUITING ·Phase: PHASE2
-
Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
NCT01931566 ·Status: TERMINATED ·Phase: PHASE3
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Pioglitazone in Alzheimer Disease
NCT00982202 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of MMFS in Early AD
NCT03531684 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin Effect on Brain Function in Insulin Resistant Elderly People
NCT03733132 ·Status: COMPLETED ·Phase: PHASE2
-
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
NCT00065169 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Early-onset Alzheimer's Disease Study Protocol
NCT03507257 ·Status: RECRUITING
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type
NCT01479855 ·Status: UNKNOWN